Understanding the Science Behind a Changing Body

Research & Medical Disclaimer

The information presented in this article is intended for educational and scientific discussion only. It explores published research surrounding peptide biology, cellular physiology and healthy ageing.

Many of the compounds discussed throughout this article remain investigational and are not approved in Australia for the diagnosis, treatment, prevention or cure of disease. References to laboratory, animal or early-stage human research should not be interpreted as evidence of established clinical effectiveness.

If you are experiencing symptoms of perimenopause or menopause, it is important to seek advice from your GP, endocrinologist, gynaecologist or another appropriately qualified healthcare professional. This article should not replace personalised medical advice, diagnosis or treatment. Instead, it aims to explain the biology behind this stage of life and discuss areas of ongoing scientific research.

Perimenopause, Menopause & Peptide Research: What Does the Science Actually Say?

For many women, perimenopause doesn't begin with a dramatic announcement. Instead, it often arrives quietly. You might notice you're waking at three o'clock every morning for no obvious reason. The weight you've comfortably managed for years suddenly begins settling around your waist. Recovery from exercise becomes slower, your joints ache more than they used to, your skin feels different and some days it seems impossible to remember why you walked into a room.

These changes can be frustrating, confusing and, for many women, deeply isolating. It's common to wonder whether you're doing something wrong. The reality is that your body is navigating one of the most significant hormonal transitions of your lifetime.

Menopause is often reduced to conversations about hot flushes and the end of menstrual cycles. Modern science tells a very different story. Researchers now understand that declining ovarian function influences metabolism, sleep, muscle, bone, cardiovascular health, collagen production, inflammation, brain function and even the tiny energy-producing structures inside every cell. It is a whole-body biological transition rather than simply a reproductive milestone.

Understanding why these changes occur helps explain why scientists have become increasingly interested in healthy ageing research, including investigations into cellular signalling molecules such as peptides.

It Doesn't Start With Menopause

Despite the name, menopause itself is actually a single point in time. A woman is considered menopausal after twelve consecutive months without a menstrual period. The journey leading to that point, however, often begins years earlier during perimenopause.

Throughout a woman's reproductive life, the brain and ovaries communicate constantly through the hypothalamic-pituitary-ovarian axis. The hypothalamus releases signalling hormones that stimulate the pituitary gland, which in turn communicates with the ovaries. The ovaries respond by producing oestrogen and progesterone, hormones that influence far more than fertility alone.

As the number of ovarian follicles naturally declines with age, this communication becomes increasingly unpredictable. Hormone production begins fluctuating rather than remaining steady. Some months oestrogen may remain relatively high, while other months it may fall sharply. Progesterone often declines earlier, creating an imbalance that contributes to many of the symptoms women experience during perimenopause.

These fluctuations help explain why symptoms can feel inconsistent. One week everything seems normal. The next, sleep becomes difficult, emotions feel heightened and your body responds differently to food, exercise and stress.

Why Does Weight Suddenly Become Harder to Manage?

One of the most common questions women ask during perimenopause is why the same diet and exercise routine no longer seems to work.

The answer is far more complex than calories alone.

Oestrogen plays an important role in regulating where the body stores fat, how muscles utilise glucose and how sensitive tissues remain to insulin. As oestrogen declines, body fat distribution often shifts away from the hips and thighs towards the abdomen. At the same time, skeletal muscle gradually decreases with age, reducing overall energy expenditure.

Sleep disruption compounds the problem further. Poor sleep influences cortisol, appetite regulation and food cravings while also reducing recovery from exercise. Together, these changes create a metabolic environment that feels completely different from earlier adulthood.

Many women blame themselves during this stage of life. In reality, they are navigating profound biological changes that extend well beyond willpower or motivation.

Sleep: The Foundation of Healthy Ageing

Sleep is one of the first systems many women notice changing, yet it is often one of the least appreciated.

Declining oestrogen influences temperature regulation, neurotransmitters and circadian rhythm. Night sweats, changes in melatonin production and shifting cortisol patterns can all contribute to fragmented sleep.

Unfortunately, poor sleep rarely stays isolated. It influences blood glucose regulation, immune function, inflammation, tissue repair, mood and cognitive performance. Researchers increasingly recognise that sleep is one of the central pillars of healthy ageing, making it an important focus in menopause research.

Rather than viewing poor sleep as simply another symptom, scientists now understand it may contribute to many of the secondary changes women experience throughout midlife.

Ageing Happens One Cell at a Time

Although the physical changes of menopause are easy to see, the biology begins much deeper.

Every cell within the body is constantly repairing itself. DNA is copied, proteins are recycled, damaged structures are removed and mitochondria generate the energy required to keep these processes functioning.

As humans age, these systems gradually become less efficient. Oxidative stress increases, mitochondria produce energy less effectively, collagen turnover slows and inflammatory signalling changes.

Scientists refer to this as biological ageing, and it is influenced by genetics, lifestyle, environmental exposures and hormonal changes.

This is one reason researchers have become interested in peptides. Rather than replacing hormones, many peptides are being studied because they participate in cellular communication and may influence biological pathways associated with ageing, metabolism and tissue maintenance.

Where Does Peptide Research Fit?

One of the most important distinctions is that peptides are not the same as hormone replacement therapy.

Hormone therapy aims to replace hormones that naturally decline during menopause. Peptides, on the other hand, are signalling molecules. Researchers study them because of the way they interact with specific biological pathways rather than because they replace oestrogen or progesterone.

Several investigational peptides have attracted scientific interest because they influence systems that are also relevant to healthy ageing.

MOTS-c is one example. Produced within the mitochondria, this peptide has been studied for its potential role in cellular energy regulation, metabolic flexibility and insulin sensitivity. Because metabolic health often changes throughout menopause, researchers continue investigating how mitochondrial signalling influences ageing. At present, however, research specifically involving menopausal women remains limited.

Another area of interest involves SS-31, also known as Elamipretide. This compound has been investigated for its interaction with mitochondrial membranes in experimental models. Scientists are exploring whether protecting mitochondrial function may influence cellular energy production and resilience during ageing. While these findings are scientifically interesting, they should not be interpreted as evidence that SS-31 treats menopausal symptoms.

Researchers have also shown interest in GHK-Cu because of its role in studies involving collagen biology and tissue remodelling. Following menopause, collagen production naturally declines, contributing to visible changes in skin thickness and elasticity. This has made collagen-related pathways an active area of research, although further clinical investigation is required before conclusions can be drawn regarding practical applications.

Epithalon occupies another unique area of longevity research. Rather than focusing on metabolism, scientists have investigated its relationship with pineal gland biology, circadian rhythm, melatonin production and cellular ageing. Some studies have explored possible interactions with telomerase activity and healthy ageing pathways, although much of this work remains preliminary and requires further independent validation.

Although NAD+ is not itself a peptide, it frequently appears alongside longevity discussions. NAD+ plays a critical role in cellular energy production and DNA repair, and researchers continue investigating how declining NAD+ levels may contribute to age-related changes in metabolism and mitochondrial function.

Looking at the Bigger Picture

One of the most important lessons emerging from modern longevity science is that healthy ageing is unlikely to depend upon a single intervention.

Regular resistance training helps preserve muscle mass and bone strength. Cardiovascular exercise supports heart health. Adequate protein intake assists muscle maintenance. Sleep supports recovery, immune function and metabolic health. Managing stress, maintaining social connections and working with qualified healthcare professionals all contribute to healthy ageing.

Peptide research represents one fascinating area within this much broader scientific landscape. While investigators continue exploring how cellular signalling molecules influence metabolism, mitochondria, collagen biology and circadian rhythm, many important questions remain unanswered.

Final Thoughts

Perimenopause and menopause represent a profound biological transition, but they are also a period of rapidly expanding scientific understanding. Researchers now recognise that this stage of life affects far more than reproductive hormones alone, influencing nearly every major system within the body.

Interest in peptide research reflects a broader shift towards understanding healthy ageing at the cellular level. Rather than searching for a single solution, scientists are investigating how metabolism, mitochondrial function, inflammation, tissue repair and circadian biology interact throughout the ageing process.

Although many investigational peptides continue to generate scientific interest, current evidence remains incomplete and further human research is essential. For women experiencing perimenopause or menopause, the strongest evidence continues to support personalised medical care, regular physical activity, resistance training, quality sleep, balanced nutrition and open discussion with qualified healthcare professionals.

The science of healthy ageing continues to evolve, and with it comes a deeper understanding of one of the most significant transitions in a woman's life.

References

1. The Menopause Society. The 2022 Hormone Therapy Position Statement.

2. Australasian Menopause Society. Information sheets and clinical guidance on perimenopause and menopause.

3. International Menopause Society. Recommendations on healthy ageing and menopause.

4. López-Otín C, et al. The Hallmarks of Aging. Cell. 2013.

5. Campisi J. Cellular Senescence and Aging. Annual Review of Physiology.

6. Lee C, et al. Research on mitochondrial-derived peptide MOTS-c and metabolic regulation. Cell Metabolism.

7. Szeto HH. Research on SS-31 (Elamipretide) and mitochondrial function. Journal of Internal Medicine.

8. Pickart L. Publications on GHK-Cu and tissue regeneration.

9. Khavinson V, Anisimov V. Publications on Epithalon, pineal peptides and healthy ageing.

10. National Institute on Aging. Resources on menopause and healthy ageing.

Research Use Only: This article discusses emerging scientific research and should not be interpreted as evidence that investigational peptides are established treatments for perimenopause, menopause or any medical condition.